We use cookies to help provide you with the best possible online experience. Learn more

Press releases

RaySearch and Princess Margaret Cancer Centre enter strategic partnership to shape the future of cancer treatment

RaySearch and Princess Margaret Cancer Centre – University Health Network in Toronto, Canada, have joined forces in a strategic partnership to further develop RayCare®*, a groundbreaking oncology information system designed for the clinical workflow needs of today and tomorrow.

RayCare is designed to unify and consolidate the different oncology disciplines – medical oncology, radiation oncology and surgical oncology – paving the way toward precision medicine. The system will improve workflows across treatment modalities and meet the demands of new techniques and approaches in cancer treatment.

The implementation of RayCare at Princess Margaret will follow a phased approach over several years. In each phase, capabilities will be added in RayCare and existing systems replaced. Ultimately, all activities in the oncology space will be coordinated through RayCare.

Mary Gospodarowicz, medical director at Princess Margaret says: “We have a strong focus on comprehensive cancer care at the Princess Margaret and uniting the different clinical disciplines is a key priority. RayCare will enable us to achieve this. It will also provide us with an integrated cancer informatics platform that builds on the significant advances we have made in this area. This is a collaboration that will shape the future of oncology systems.”

Johan Löf, CEO of RaySearch, says: “PMH is one of the most important cancer centers worldwide, and their experience and insight will be invaluable in the continuing development of RayCare. Our partnership, which spans more than a decade, is one of the pillars supporting RaySearch’s work to advance cancer treatment. Together we are taking cancer treatment to new levels and enabling truly patient-centered care.”

About Princess Margaret Cancer Centre

The Princess Margaret is a comprehensive cancer center with over 17000 new patients per year and over 3,000 staff. Its 850,000 square feet house 202 in-patient beds, over 416,000 square feet of research space and 17 radiation treatment machines on a single site, making it one of the largest comprehensive cancer treatment facilities in the world and the largest radiation treatment center in Canada. Through ongoing research, education and innovation, Princess Margaret continues to be on the frontiers of medical, surgical and radiation oncology, embracing the latest technology and international best-practices and setting standards for patient care.

About RayCare

RayCare represents the future of OIS technology, developed from the ground up by RaySearch to support the complex logistical challenges of modern, large-scale radiation therapy centers. RayCare will integrate the high-performance radiation therapy algorithms available in RayStation with advanced features for clinical resource optimization, workflow automation and adaptive radiation therapy.

About RayStation

RayStation integrates all RaySearch’s advanced treatment planning solutions into a flexible treatment planning system. It combines unique features such as multi-criteria optimization tools with full support for 4D adaptive radiation therapy. It also includes functionality such as RaySearch’s market-leading algorithms for IMRT and VMAT optimization and highly accurate dose engines for photon, electron, proton and carbon ion therapy. The system is built on the latest software architecture and features a graphical user interface with state-of-the-art usability.

About RaySearch

RaySearch Laboratories AB (publ) is a medical technology company that develops innovative software solutions for improved cancer treatment. RaySearch markets the RayStation treatment planning system and the RayCare oncology information system to clinics all over the world and distributes products through licensing agreements with leading medical technology companies. RaySearch’s software is used by over 2,600 clinics in more than 65 countries. The company was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the share has been listed on Nasdaq Stockholm since 2003.

To learn more about RaySearch, go to: www.raysearchlabs.com

* Subject to regulatory clearance in some markets.

For further information, please contact:

Johan Löf, President and CEO, RaySearch Laboratories AB (publ)

Telephone: +46 (0)8-510 530 00


Peter Thysell, CFO, RaySearch Laboratories AB (publ)

Telephone: +46 (0)70 661 05 59